| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Military Personnel | 13 | 2005 | 19 |
Why?
|
Vascular Surgical Procedures | 22 | 1998 | 39 |
Why?
|
War | 12 | 2003 | 7 |
Why?
|
Venous Thrombosis | 6 | 2001 | 45 |
Why?
|
Veins | 11 | 1997 | 41 |
Why?
|
Multiple Trauma | 4 | 2008 | 12 |
Why?
|
Blood Vessels | 6 | 1992 | 65 |
Why?
|
Wounds and Injuries | 6 | 2006 | 68 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2006 | 25 |
Why?
|
Blast Injuries | 6 | 2005 | 2 |
Why?
|
Glioma | 5 | 2006 | 51 |
Why?
|
Arteries | 8 | 1993 | 56 |
Why?
|
Wounds, Penetrating | 4 | 1993 | 21 |
Why?
|
Wounds, Gunshot | 7 | 1992 | 23 |
Why?
|
Hospitals, Military | 5 | 2005 | 4 |
Why?
|
Stents | 9 | 1998 | 55 |
Why?
|
Military Medicine | 4 | 2005 | 14 |
Why?
|
Ultrasonography, Interventional | 5 | 1999 | 32 |
Why?
|
Lower Extremity | 2 | 2010 | 15 |
Why?
|
Aneurysm, False | 4 | 2003 | 15 |
Why?
|
Carotid Artery Injuries | 2 | 2007 | 17 |
Why?
|
Venous Insufficiency | 6 | 1992 | 5 |
Why?
|
Angiography | 7 | 1992 | 63 |
Why?
|
Treatment Outcome | 25 | 1996 | 661 |
Why?
|
Brain Neoplasms | 4 | 2006 | 116 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2009 | 15 |
Why?
|
Tomography, X-Ray Computed | 9 | 2002 | 321 |
Why?
|
Femoral Artery | 3 | 1999 | 52 |
Why?
|
Humans | 83 | 1991 | 1856 |
Why?
|
Vena Cava Filters | 3 | 2009 | 8 |
Why?
|
Renal Dialysis | 3 | 2009 | 56 |
Why?
|
Varicose Veins | 6 | 1998 | 9 |
Why?
|
Extremities | 6 | 1992 | 32 |
Why?
|
Anticoagulants | 6 | 1996 | 88 |
Why?
|
Arm Injuries | 3 | 2007 | 8 |
Why?
|
Leg Injuries | 3 | 2007 | 10 |
Why?
|
Venous Thromboembolism | 3 | 2006 | 15 |
Why?
|
RNA, Small Interfering | 3 | 2007 | 116 |
Why?
|
Saphenous Vein | 4 | 1992 | 15 |
Why?
|
Upper Extremity | 3 | 2006 | 15 |
Why?
|
Polytetrafluoroethylene | 4 | 1997 | 23 |
Why?
|
United States | 16 | 2005 | 604 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 1996 | 19 |
Why?
|
Societies, Medical | 4 | 2003 | 90 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2004 | 94 |
Why?
|
Limb Salvage | 2 | 2008 | 8 |
Why?
|
Aortic Aneurysm, Abdominal | 5 | 1994 | 20 |
Why?
|
Angioplasty | 2 | 1999 | 22 |
Why?
|
Pulmonary Embolism | 2 | 2008 | 48 |
Why?
|
Anoxia | 3 | 2006 | 85 |
Why?
|
Vascular System Injuries | 1 | 2011 | 1 |
Why?
|
Male | 50 | 1991 | 1553 |
Why?
|
Adult | 35 | 1992 | 1317 |
Why?
|
RNA Interference | 2 | 2007 | 75 |
Why?
|
Neck Injuries | 2 | 2006 | 10 |
Why?
|
Heparin | 3 | 1998 | 87 |
Why?
|
Gene Silencing | 3 | 2006 | 32 |
Why?
|
Varicose Ulcer | 1 | 2010 | 3 |
Why?
|
Vena Cava, Inferior | 1 | 2010 | 26 |
Why?
|
Iraq | 8 | 2005 | 7 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 57 |
Why?
|
Predictive Value of Tests | 8 | 2002 | 321 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 46 |
Why?
|
Explosions | 1 | 2009 | 2 |
Why?
|
Embolism | 1 | 2009 | 14 |
Why?
|
Meningioma | 5 | 2005 | 26 |
Why?
|
Fracture Fixation, Internal | 1 | 2009 | 20 |
Why?
|
Aneurysm | 3 | 1991 | 20 |
Why?
|
Hip Fractures | 1 | 2009 | 19 |
Why?
|
Blood Vessel Prosthesis | 4 | 1999 | 22 |
Why?
|
Middle Aged | 35 | 1991 | 1161 |
Why?
|
Hospital Volunteers | 1 | 2009 | 2 |
Why?
|
Embolization, Therapeutic | 4 | 2002 | 37 |
Why?
|
Head Injuries, Penetrating | 1 | 2007 | 1 |
Why?
|
Thrombophilia | 1 | 2007 | 10 |
Why?
|
Lipoprotein(a) | 1 | 2007 | 12 |
Why?
|
Female | 40 | 1992 | 1643 |
Why?
|
Subclavian Vein | 2 | 2001 | 15 |
Why?
|
Postoperative Complications | 5 | 1994 | 305 |
Why?
|
Physical Examination | 1 | 2007 | 71 |
Why?
|
Leg | 5 | 1995 | 75 |
Why?
|
Vascular Diseases | 4 | 2002 | 60 |
Why?
|
Afghanistan | 6 | 2005 | 3 |
Why?
|
Meningeal Neoplasms | 4 | 2005 | 30 |
Why?
|
Trauma Centers | 1 | 2006 | 17 |
Why?
|
Practice Guidelines as Topic | 4 | 2006 | 174 |
Why?
|
Carotid Stenosis | 4 | 1996 | 33 |
Why?
|
Peripheral Vascular Diseases | 2 | 2001 | 26 |
Why?
|
Pelvic Pain | 2 | 2001 | 17 |
Why?
|
Mice, Nude | 7 | 2006 | 72 |
Why?
|
Aged | 24 | 1993 | 988 |
Why?
|
Thrombectomy | 3 | 2003 | 12 |
Why?
|
Retrospective Studies | 10 | 1995 | 653 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2002 | 7 |
Why?
|
Collagenases | 1 | 2002 | 21 |
Why?
|
Endarterectomy, Carotid | 5 | 1996 | 16 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2005 | 24 |
Why?
|
Phlebography | 4 | 2006 | 28 |
Why?
|
Axillary Vein | 1 | 2001 | 3 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2001 | 9 |
Why?
|
Renal Veins | 1 | 2001 | 13 |
Why?
|
Time Factors | 11 | 1999 | 896 |
Why?
|
Transfection | 4 | 2007 | 237 |
Why?
|
Constriction, Pathologic | 4 | 2001 | 65 |
Why?
|
Recurrence | 6 | 1996 | 261 |
Why?
|
Young Adult | 5 | 2006 | 380 |
Why?
|
Sclerotherapy | 3 | 2002 | 6 |
Why?
|
Alloys | 1 | 1999 | 16 |
Why?
|
Iliac Artery | 1 | 1999 | 13 |
Why?
|
Iraq War, 2003 - | 2 | 2008 | 5 |
Why?
|
Thrombophlebitis | 2 | 1993 | 23 |
Why?
|
Suture Techniques | 3 | 1999 | 48 |
Why?
|
Severity of Illness Index | 6 | 2002 | 358 |
Why?
|
Syndrome | 4 | 2001 | 142 |
Why?
|
Risk Factors | 8 | 1995 | 555 |
Why?
|
Registries | 3 | 1998 | 83 |
Why?
|
Ligation | 3 | 1992 | 29 |
Why?
|
Vietnam Conflict | 2 | 2006 | 1 |
Why?
|
Polymerase Chain Reaction | 3 | 2004 | 279 |
Why?
|
History, 20th Century | 3 | 2005 | 111 |
Why?
|
Plethysmography | 2 | 1992 | 11 |
Why?
|
Factor V | 1 | 1996 | 12 |
Why?
|
Pyrazoles | 2 | 2005 | 42 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2005 | 47 |
Why?
|
Protein C | 1 | 1996 | 28 |
Why?
|
Sulfonamides | 2 | 2005 | 74 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2004 | 41 |
Why?
|
Inguinal Canal | 1 | 1995 | 5 |
Why?
|
Risk Assessment | 5 | 2006 | 324 |
Why?
|
Ki-67 Antigen | 4 | 2006 | 20 |
Why?
|
Wounds, Stab | 2 | 1992 | 6 |
Why?
|
Cell Line, Tumor | 5 | 2007 | 208 |
Why?
|
Adolescent | 8 | 1992 | 891 |
Why?
|
Wound Healing | 2 | 1999 | 106 |
Why?
|
Regional Blood Flow | 3 | 1999 | 105 |
Why?
|
Arteriosclerosis | 3 | 1995 | 54 |
Why?
|
Arterial Occlusive Diseases | 1 | 1994 | 36 |
Why?
|
Ventricular Function, Left | 1 | 1994 | 41 |
Why?
|
Pulmonary Artery | 1 | 1994 | 58 |
Why?
|
Transplantation, Heterologous | 3 | 2007 | 57 |
Why?
|
Follow-Up Studies | 6 | 1996 | 553 |
Why?
|
Mice | 7 | 2006 | 623 |
Why?
|
Aged, 80 and over | 7 | 1994 | 599 |
Why?
|
Terminology as Topic | 2 | 2010 | 81 |
Why?
|
Anastomosis, Surgical | 2 | 1999 | 45 |
Why?
|
Wounds, Nonpenetrating | 1 | 1993 | 32 |
Why?
|
Glucose Transporter Type 1 | 2 | 2007 | 3 |
Why?
|
Surgical Procedures, Elective | 4 | 1999 | 31 |
Why?
|
Patient Selection | 2 | 2010 | 155 |
Why?
|
Angiography, Digital Subtraction | 2 | 1991 | 18 |
Why?
|
Ribs | 1 | 2011 | 8 |
Why?
|
Prospective Studies | 6 | 1992 | 545 |
Why?
|
Clavicle | 1 | 2011 | 15 |
Why?
|
Tumor Cells, Cultured | 4 | 2005 | 233 |
Why?
|
Hemostatic Techniques | 2 | 2008 | 8 |
Why?
|
Endovascular Procedures | 1 | 2011 | 2 |
Why?
|
Osteotomy | 1 | 2011 | 19 |
Why?
|
Adrenalectomy | 1 | 2011 | 18 |
Why?
|
Carotid Arteries | 3 | 1999 | 51 |
Why?
|
Central Venous Pressure | 1 | 2010 | 5 |
Why?
|
Popliteal Artery | 1 | 1991 | 13 |
Why?
|
Collateral Circulation | 1 | 2010 | 13 |
Why?
|
Immunoenzyme Techniques | 2 | 2007 | 125 |
Why?
|
Pheochromocytoma | 1 | 2011 | 21 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2011 | 25 |
Why?
|
Blotting, Western | 3 | 2004 | 275 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2007 | 35 |
Why?
|
Decompression, Surgical | 1 | 2011 | 27 |
Why?
|
Adrenal Glands | 1 | 2011 | 35 |
Why?
|
Vertebral Artery | 2 | 2006 | 15 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 135 |
Why?
|
Surface Plasmon Resonance | 1 | 2010 | 10 |
Why?
|
DNA Methylation | 1 | 2010 | 29 |
Why?
|
Angioplasty, Balloon | 2 | 1998 | 35 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2010 | 21 |
Why?
|
Bone Nails | 1 | 2009 | 3 |
Why?
|
Program Development | 1 | 2010 | 61 |
Why?
|
Coronary Stenosis | 1 | 2009 | 6 |
Why?
|
Health Status Indicators | 1 | 2010 | 66 |
Why?
|
Animals | 8 | 1999 | 1031 |
Why?
|
Embolectomy | 1 | 2009 | 2 |
Why?
|
Aortic Rupture | 1 | 2009 | 18 |
Why?
|
Computer-Assisted Instruction | 1 | 2009 | 16 |
Why?
|
Aortography | 2 | 2005 | 15 |
Why?
|
Preoperative Care | 3 | 1994 | 93 |
Why?
|
Vascular Patency | 3 | 1999 | 28 |
Why?
|
Hemodynamics | 2 | 1992 | 131 |
Why?
|
Myocardial Infarction | 1 | 1995 | 129 |
Why?
|
Models, Economic | 1 | 2009 | 14 |
Why?
|
Preventive Health Services | 1 | 2010 | 36 |
Why?
|
DNA | 2 | 1996 | 262 |
Why?
|
Afghan Campaign 2001- | 1 | 2009 | 5 |
Why?
|
Red Cross | 1 | 2009 | 2 |
Why?
|
Sensitivity and Specificity | 3 | 1998 | 427 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 40 |
Why?
|
Germany | 1 | 2009 | 21 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2009 | 19 |
Why?
|
Neovascularization, Pathologic | 2 | 2006 | 64 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 224 |
Why?
|
Luminescent Agents | 1 | 2008 | 4 |
Why?
|
Health Care Costs | 1 | 2009 | 73 |
Why?
|
Weapons | 1 | 2007 | 1 |
Why?
|
Laparoscopy | 1 | 2011 | 52 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 167 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 70 |
Why?
|
Iran | 1 | 2007 | 4 |
Why?
|
Glioblastoma | 1 | 2008 | 44 |
Why?
|
Ethylenediamines | 1 | 2007 | 4 |
Why?
|
Neck | 3 | 1997 | 31 |
Why?
|
Dipeptides | 1 | 2007 | 17 |
Why?
|
Renal Insufficiency | 1 | 2007 | 21 |
Why?
|
Reproducibility of Results | 2 | 2007 | 391 |
Why?
|
Program Evaluation | 1 | 2009 | 115 |
Why?
|
Luciferases | 1 | 2008 | 70 |
Why?
|
Immunohistochemistry | 3 | 2004 | 355 |
Why?
|
Computer Simulation | 1 | 2009 | 134 |
Why?
|
Time | 1 | 2007 | 41 |
Why?
|
Polymers | 1 | 2007 | 60 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 75 |
Why?
|
Cell Proliferation | 5 | 2005 | 227 |
Why?
|
World War I | 1 | 2006 | 1 |
Why?
|
World War II | 1 | 2006 | 2 |
Why?
|
Compartment Syndromes | 1 | 2006 | 6 |
Why?
|
Gene Therapy | 1 | 2009 | 89 |
Why?
|
Fascia | 1 | 2006 | 15 |
Why?
|
Blood Transfusion | 1 | 2008 | 59 |
Why?
|
DNA, Complementary | 1 | 2007 | 139 |
Why?
|
Travel | 1 | 2006 | 10 |
Why?
|
Apoptosis | 3 | 2005 | 265 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 94 |
Why?
|
Edema | 2 | 2001 | 67 |
Why?
|
Balloon Dilation | 2 | 2002 | 42 |
Why?
|
Aortic Coarctation | 1 | 2005 | 13 |
Why?
|
Graft Occlusion, Vascular | 2 | 1999 | 22 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 204 |
Why?
|
Clinical Competence | 2 | 2003 | 130 |
Why?
|
Endolymphatic Sac | 1 | 2004 | 2 |
Why?
|
Cell Division | 1 | 2007 | 273 |
Why?
|
von Hippel-Lindau Disease | 1 | 2004 | 10 |
Why?
|
Fellowships and Scholarships | 1 | 2005 | 34 |
Why?
|
Ischemia | 2 | 2001 | 65 |
Why?
|
Hyperpigmentation | 1 | 2003 | 4 |
Why?
|
Arteriovenous Fistula | 1 | 2003 | 21 |
Why?
|
Hemostasis, Surgical | 1 | 2003 | 11 |
Why?
|
Questionnaires | 1 | 2009 | 360 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 66 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 126 |
Why?
|
Cough | 1 | 2003 | 20 |
Why?
|
Catheterization, Peripheral | 1 | 2003 | 21 |
Why?
|
Choristoma | 1 | 2003 | 20 |
Why?
|
Subclavian Artery | 1 | 2003 | 22 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 51 |
Why?
|
Tryptases | 1 | 2002 | 3 |
Why?
|
Point Mutation | 1 | 2004 | 122 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2002 | 11 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 277 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2002 | 13 |
Why?
|
Catheterization | 1 | 2003 | 47 |
Why?
|
Multivariate Analysis | 2 | 1994 | 225 |
Why?
|
Hypertension, Renovascular | 1 | 2002 | 9 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 28 |
Why?
|
Aneurysm, Dissecting | 1 | 2002 | 19 |
Why?
|
Iliac Aneurysm | 1 | 2001 | 4 |
Why?
|
Tissue Distribution | 1 | 2002 | 124 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 121 |
Why?
|
Repressor Proteins | 1 | 2004 | 96 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2001 | 6 |
Why?
|
Coronary Artery Bypass | 1 | 2002 | 46 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 114 |
Why?
|
Carotid Body Tumor | 1 | 2000 | 6 |
Why?
|
Disease Progression | 3 | 2000 | 244 |
Why?
|
Reference Values | 1 | 2002 | 278 |
Why?
|
Magnetic Resonance Imaging | 4 | 2000 | 294 |
Why?
|
Fibrin Tissue Adhesive | 1 | 1999 | 6 |
Why?
|
Kidney Diseases | 1 | 2001 | 90 |
Why?
|
Hemostatics | 1 | 1999 | 15 |
Why?
|
Cerebrovascular Disorders | 2 | 1996 | 66 |
Why?
|
Hemorheology | 1 | 1999 | 12 |
Why?
|
Carotid Artery Diseases | 1 | 2000 | 36 |
Why?
|
Prosthesis Design | 1 | 1999 | 44 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1999 | 69 |
Why?
|
Surface Properties | 1 | 1999 | 63 |
Why?
|
Fibrin | 1 | 1999 | 23 |
Why?
|
Molecular Structure | 2 | 2007 | 67 |
Why?
|
Dogs | 1 | 1999 | 159 |
Why?
|
Vimentin | 2 | 2008 | 21 |
Why?
|
Renal Artery Obstruction | 1 | 1998 | 19 |
Why?
|
Tunica Intima | 1 | 1999 | 31 |
Why?
|
Femoral Vein | 1 | 1998 | 16 |
Why?
|
Magnetic Resonance Angiography | 1 | 1998 | 32 |
Why?
|
Transcription Factors | 1 | 2004 | 201 |
Why?
|
Jugular Veins | 1 | 1997 | 21 |
Why?
|
Case-Control Studies | 2 | 1995 | 283 |
Why?
|
Antibody Formation | 1 | 1998 | 89 |
Why?
|
Veterans | 1 | 1998 | 16 |
Why?
|
Hematoma | 1 | 1997 | 36 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 1998 | 27 |
Why?
|
Neoplasm Invasiveness | 2 | 2008 | 105 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1999 | 138 |
Why?
|
Cell Movement | 1 | 1999 | 163 |
Why?
|
Protein S Deficiency | 1 | 1996 | 6 |
Why?
|
Protein C Deficiency | 1 | 1996 | 6 |
Why?
|
Antithrombin III | 1 | 1996 | 9 |
Why?
|
Contraceptives, Oral | 1 | 1996 | 10 |
Why?
|
Chronic Disease | 3 | 1998 | 267 |
Why?
|
New York | 2 | 2010 | 422 |
Why?
|
Glutamine | 1 | 1996 | 27 |
Why?
|
Lymphedema | 1 | 1995 | 4 |
Why?
|
Sarcoma, Kaposi | 1 | 1995 | 15 |
Why?
|
Kidney | 2 | 1994 | 223 |
Why?
|
Drug Resistance | 1 | 1996 | 83 |
Why?
|
Foot Diseases | 1 | 1995 | 18 |
Why?
|
Arginine | 1 | 1996 | 57 |
Why?
|
Tourniquets | 2 | 2001 | 2 |
Why?
|
Tumor Markers, Biological | 2 | 2008 | 112 |
Why?
|
Cell Survival | 2 | 2006 | 229 |
Why?
|
Thromboembolism | 1 | 1996 | 27 |
Why?
|
Pulmonary Wedge Pressure | 1 | 1994 | 9 |
Why?
|
Constriction | 1 | 1994 | 18 |
Why?
|
Leukocyte Count | 1 | 1995 | 94 |
Why?
|
Premedication | 1 | 1994 | 22 |
Why?
|
Cohort Studies | 2 | 2008 | 332 |
Why?
|
Endothelium, Vascular | 1 | 1999 | 139 |
Why?
|
RNA, Messenger | 1 | 2002 | 394 |
Why?
|
Echocardiography, Transesophageal | 1 | 1994 | 33 |
Why?
|
Monitoring, Intraoperative | 1 | 1994 | 31 |
Why?
|
Blood Volume | 1 | 1994 | 35 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 59 |
Why?
|
Cyclooxygenase 2 | 2 | 2005 | 77 |
Why?
|
Diagnosis, Differential | 1 | 1997 | 402 |
Why?
|
Incidence | 2 | 2006 | 336 |
Why?
|
Medical History Taking | 1 | 1994 | 53 |
Why?
|
Odds Ratio | 1 | 1995 | 157 |
Why?
|
Heart Diseases | 1 | 1995 | 92 |
Why?
|
Disease Models, Animal | 2 | 2008 | 349 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1995 | 85 |
Why?
|
Popliteal Vein | 1 | 1992 | 9 |
Why?
|
Air | 1 | 1992 | 31 |
Why?
|
Logistic Models | 1 | 1995 | 251 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 431 |
Why?
|
Skin Neoplasms | 1 | 1995 | 97 |
Why?
|
Obesity | 1 | 1996 | 149 |
Why?
|
Compression Bandages | 1 | 2011 | 1 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 18 |
Why?
|
Incidental Findings | 1 | 2011 | 16 |
Why?
|
Child, Preschool | 1 | 1997 | 554 |
Why?
|
Language | 1 | 2010 | 23 |
Why?
|
Pregnancy | 1 | 1996 | 455 |
Why?
|
CpG Islands | 1 | 2010 | 26 |
Why?
|
ROC Curve | 1 | 2010 | 80 |
Why?
|
Disability Evaluation | 1 | 2010 | 61 |
Why?
|
Surgical Procedures, Minimally Invasive | 1 | 2009 | 23 |
Why?
|
Markov Chains | 1 | 2009 | 25 |
Why?
|
Hospital Costs | 1 | 2009 | 26 |
Why?
|
Foreign Bodies | 1 | 2010 | 36 |
Why?
|
Quality-Adjusted Life Years | 1 | 2009 | 22 |
Why?
|
Mutation | 1 | 1996 | 340 |
Why?
|
Internationality | 1 | 2009 | 28 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 125 |
Why?
|
Academic Medical Centers | 1 | 2010 | 65 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 105 |
Why?
|
Nanoparticles | 1 | 2009 | 13 |
Why?
|
Injections, Intravenous | 1 | 2009 | 105 |
Why?
|
HIV-1 | 1 | 1995 | 93 |
Why?
|
Blood Flow Velocity | 1 | 2009 | 72 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 89 |
Why?
|
Oligopeptides | 1 | 2009 | 56 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 118 |
Why?
|
Kanamycin Kinase | 1 | 2008 | 2 |
Why?
|
Luminescence | 1 | 2008 | 3 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 163 |
Why?
|
Child | 1 | 1997 | 749 |
Why?
|
Equipment Design | 1 | 2009 | 132 |
Why?
|
Mucin-1 | 1 | 2008 | 12 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 31 |
Why?
|
Skull Base Neoplasms | 1 | 2008 | 8 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 52 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 105 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 123 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 137 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2008 | 37 |
Why?
|
Disease-Free Survival | 1 | 2008 | 102 |
Why?
|
Pilot Projects | 1 | 2009 | 264 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 67 |
Why?
|
Surgical Wound Infection | 1 | 2008 | 41 |
Why?
|
Accidents, Traffic | 1 | 2008 | 48 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 66 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 45 |
Why?
|
Graft Survival | 1 | 2008 | 74 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 41 |
Why?
|
Guideline Adherence | 1 | 2008 | 64 |
Why?
|
Recombinant Proteins | 1 | 2010 | 290 |
Why?
|
Research Design | 1 | 2009 | 169 |
Why?
|
Hydroxyurea | 1 | 2006 | 12 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 94 |
Why?
|
Thrombolytic Therapy | 1 | 2007 | 42 |
Why?
|
Protein Binding | 1 | 2010 | 256 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 65 |
Why?
|
Cell Hypoxia | 1 | 2007 | 31 |
Why?
|
Thrombosis | 1 | 2009 | 105 |
Why?
|
Venous Pressure | 1 | 2006 | 5 |
Why?
|
Oxidation-Reduction | 1 | 2007 | 124 |
Why?
|
Flow Cytometry | 1 | 2009 | 216 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2007 | 74 |
Why?
|
Genotype | 1 | 2008 | 175 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 48 |
Why?
|
Asia | 1 | 2006 | 11 |
Why?
|
Stress, Physiological | 1 | 2007 | 76 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 64 |
Why?
|
Survival Analysis | 1 | 2008 | 205 |
Why?
|
Mifepristone | 1 | 2006 | 30 |
Why?
|
DNA Damage | 1 | 2007 | 66 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2007 | 176 |
Why?
|
Internship and Residency | 1 | 2009 | 175 |
Why?
|
Acute Disease | 1 | 2007 | 271 |
Why?
|
Factor VIII | 1 | 2007 | 28 |
Why?
|
Quality of Life | 1 | 2009 | 188 |
Why?
|
Body Weights and Measures | 1 | 2005 | 5 |
Why?
|
Base Sequence | 1 | 2010 | 371 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2005 | 45 |
Why?
|
Up-Regulation | 1 | 2007 | 183 |
Why?
|
Combined Modality Therapy | 2 | 1995 | 219 |
Why?
|
Prognosis | 1 | 2008 | 388 |
Why?
|
Single-Blind Method | 1 | 2005 | 86 |
Why?
|
Observer Variation | 1 | 2005 | 103 |
Why?
|
Aorta, Thoracic | 1 | 2005 | 54 |
Why?
|
Survival Rate | 1 | 2007 | 250 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2004 | 13 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2004 | 10 |
Why?
|
Loss of Heterozygosity | 1 | 2004 | 17 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 58 |
Why?
|
Mixed Function Oxygenases | 1 | 2004 | 25 |
Why?
|
Microsurgery | 1 | 2004 | 27 |
Why?
|
Carbonic Anhydrases | 1 | 2004 | 11 |
Why?
|
Punctures | 1 | 2003 | 22 |
Why?
|
Prevalence | 1 | 2006 | 281 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 110 |
Why?
|
Equipment Failure | 1 | 2003 | 44 |
Why?
|
Exons | 1 | 2004 | 91 |
Why?
|
Cytokines | 1 | 2007 | 207 |
Why?
|
Vulva | 1 | 2002 | 13 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 56 |
Why?
|
Spinal Cord | 1 | 2004 | 94 |
Why?
|
Calcinosis | 1 | 2002 | 54 |
Why?
|
Cardiomyopathies | 1 | 2002 | 43 |
Why?
|
DNA Primers | 1 | 2004 | 208 |
Why?
|
Renal Artery | 1 | 2002 | 33 |
Why?
|
Gravity Suits | 1 | 2001 | 4 |
Why?
|
Statistics as Topic | 1 | 2002 | 133 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 110 |
Why?
|
Coronary Artery Disease | 1 | 2002 | 56 |
Why?
|
Antihypertensive Agents | 1 | 2002 | 54 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 190 |
Why?
|
Membrane Proteins | 1 | 2005 | 233 |
Why?
|
Lymph Node Excision | 1 | 2000 | 30 |
Why?
|
Life Tables | 1 | 2000 | 33 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1999 | 3 |
Why?
|
Gene Expression | 1 | 2004 | 291 |
Why?
|
Ischemic Attack, Transient | 1 | 2000 | 28 |
Why?
|
Lymphatic Metastasis | 1 | 2000 | 77 |
Why?
|
Intraoperative Care | 1 | 1999 | 34 |
Why?
|
Blood Loss, Surgical | 1 | 1999 | 28 |
Why?
|
Needles | 1 | 1999 | 24 |
Why?
|
Platelet Count | 1 | 1998 | 39 |
Why?
|
Platelet Factor 4 | 1 | 1998 | 10 |
Why?
|
Antigen-Antibody Complex | 1 | 1998 | 34 |
Why?
|
Hypertension, Renal | 1 | 1998 | 11 |
Why?
|
Vietnam | 1 | 1998 | 5 |
Why?
|
District of Columbia | 1 | 1998 | 5 |
Why?
|
Thrombin | 1 | 1999 | 41 |
Why?
|
Carotid Artery, Internal | 1 | 1998 | 27 |
Why?
|
Thrombocytopenia | 1 | 1998 | 46 |
Why?
|
Hypertension | 1 | 2001 | 161 |
Why?
|
Aorta | 1 | 1998 | 69 |
Why?
|
Antibodies | 1 | 1998 | 159 |
Why?
|
Stroke | 1 | 2000 | 59 |
Why?
|
Brain | 1 | 2004 | 305 |
Why?
|
Reoperation | 1 | 1996 | 106 |
Why?
|
Immunoglobulin G | 1 | 1998 | 191 |
Why?
|
Fatal Outcome | 1 | 1995 | 86 |
Why?
|
Arm | 1 | 1993 | 48 |
Why?
|
Functional Laterality | 1 | 1993 | 50 |
Why?
|
Age Distribution | 1 | 1993 | 127 |
Why?
|
Body Mass Index | 1 | 1993 | 122 |
Why?
|
